Loading...
DRI Healthcare Trust
DHT-UN.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$14.12
CA$0.15(1.07%)
DRI Healthcare Trust (DHT-UN.TO) Financial Performance & Income Statement Overview
Review DRI Healthcare Trust’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.97%
↑ 17.97%
Operating Income Growth
-118.08%
↓ 118.08%
Net Income Growth
-103.68%
↓ 103.68%
Operating Cash Flow Growth
103.46%
↑ 103.46%
Operating Margin
-10.01%
↓ 10.007%
Gross Margin
81.92%
↑ 81.92%
Net Profit Margin
0.93%
↑ 0.93%
ROE
0.27%
↑ 0.27%
ROIC
-1.60%
↓ 1.60%
DRI Healthcare Trust (DHT-UN.TO) Income Statement & Financial Overview
Review DRI Healthcare Trust's (DHT-UN.TO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $47.43M | $31.71M | $29.32M | $25.05M |
| Cost of Revenue | $17.25M | $0.00 | -$12.29M | $0.00 |
| Gross Profit | $30.17M | $31.71M | $41.60M | $25.05M |
| Gross Profit Ratio | $0.64 | $1.00 | $1.42 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.20M | $6.05M | $2.51M | $3.60M |
| Operating Expenses | $40.43M | $31.71M | $31.45M | $31.25M |
| Total Costs & Expenses | $40.43M | $31.71M | $30.14M | $31.25M |
| Interest Income | $382000.00 | $774000.00 | $577000.00 | $722000.00 |
| Interest Expense | $9.49M | $8.55M | $8.64M | $8.40M |
| Depreciation & Amortization | $25.31M | $26.10M | $25.64M | $25.09M |
| EBITDA | -$735040.00 | $0.00 | $31.55M | $0.00 |
| EBITDA Ratio | -$0.02 | $0.00 | $1.08 | $0.00 |
| Operating Income | $7.001M | $0.00 | -$20.60M | -$6.20M |
| Operating Income Ratio | $0.15 | $0.00 | -$0.70 | -$0.25 |
| Other Income/Expenses (Net) | $0.00 | -$1.69M | $18.47M | $8.51M |
| Income Before Tax | $7.001M | -$1.69M | -$2.13M | -$6.20M |
| Income Before Tax Ratio | $0.15 | -$0.05 | -$0.07 | -$0.25 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$18.78M |
| Net Income | $7.001M | -$1.69M | -$2.13M | -$6.20M |
| Net Income Ratio | $0.15 | -$0.05 | -$0.07 | -$0.25 |
| EPS | $0.12 | -$0.03 | -$0.04 | -$0.11 |
| Diluted EPS | $0.12 | -$0.03 | -$0.04 | -$0.11 |
| Weighted Avg Shares Outstanding | $39.11M | $56.29M | $53.33M | $56.36M |
| Weighted Avg Shares Outstanding (Diluted) | $39.39M | $56.29M | $56.43M | $56.36M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan